Announcing the new Tapestri scMRD Assay for AML. Learn More ›

Home Resources Publications A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent…

FILTER RESOURCES

ALL FEATURED PUBLICATIONS SCIENTIFIC PRESENTATIONS RESEARCHER SPOTLIGHTS VIDEOS BROCHURES DATASETS USER GUIDES TECHNICAL NOTES POSTERS

publication

A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN

Xiao, W. et al.
Blood Advances (2020)

Abstract

Myeloid neoplasm (MPN) clones can evolve from acute myeloid leukemia to gain dominance with isocitrate dehydrogenase inhibition.
Pro-differentiation agents such as ivosidenib can unmask MPN sequelae.

Authors

Xiao, W., Miles, L.A.., Bowman R.L., Durani, V., Tian H.S., DelGaudio, N.L., Mishra, T., Zhu, M. Zhang, Y., Stump, S.E.., Tallman, M.S., Levine, R.L.., Cai, S.F.

VIEW

Phenotypic signatures of immune selection in HIV-1 reservoir cells

Mutated cells mediate distinct inflammatory responses in clonal hematopoiesis

J. Brett Heimlich

scTAM-seq enables targeted high-confidence analysis of DNA methylation in single cells

Genome Biology (2022)

Single cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia

Troy T. Robinson